{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:18:14Z","timestamp":1784927894865,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011234","name":"Bio-Rad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jmoldx.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:58:01Z","timestamp":1542934681000},"page":"214-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens"],"prefix":"10.1016","volume":"21","author":[{"given":"Miguel","family":"Alcaide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bushell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-2107","authenticated-orcid":false,"given":"Hui-Li","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Karasinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Renouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-1936","authenticated-orcid":false,"given":"Mathilde Couetoux du","family":"Tertre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Batist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen F.","family":"Kennecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Karsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2018.09.007_bib1","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib2","doi-asserted-by":"crossref","first-page":"150960","DOI":"10.1155\/2010\/150960","article-title":"Clinical relevance of\u00a0KRAS in human cancers","volume":"2010","author":"Jancik","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2015.11.012","article-title":"Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: hopes and realities","volume":"54","author":"Bournet","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/bjc.2013.118","article-title":"KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers","volume":"108","author":"Phipps","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib5","doi-asserted-by":"crossref","first-page":"8373","DOI":"10.18632\/oncotarget.7080","article-title":"KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: a meta-analysis of 41 studies","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2174\/138945012800564103","article-title":"Molecular pathology of pancreatic cancer: from bench-to-bedside translation","volume":"13","author":"Corbo","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/bjc.2014.215","article-title":"Oncogenic KRAS signalling in pancreatic cancer","volume":"111","author":"Eser","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.trecan.2017.04.005","article-title":"Molecular events in the natural history of pancreatic cancer","volume":"3","author":"Oldfield","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib10","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","volume":"6","author":"Roberts","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib12","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib13","doi-asserted-by":"crossref","first-page":"22978","DOI":"10.1038\/srep22978","article-title":"Endoscopic ultrasound-guided fine needle core biopsy for the diagnosis of pancreatic malignant lesions: a systematic review and meta-analysis","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2353\/jmoldx.2009.080124","article-title":"A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses","volume":"11","author":"Boyd","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib15","doi-asserted-by":"crossref","first-page":"e0149833","DOI":"10.1371\/journal.pone.0149833","article-title":"Whole genome sequencing of newly established pancreatic cancer lines identifies novel somatic mutation (c.2587G>A) in axon guidance receptor Plexin A1 as enhancer of proliferation and invasion","volume":"11","author":"Sorber","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib17","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib18","doi-asserted-by":"crossref","first-page":"e0136407","DOI":"10.1371\/journal.pone.0136407","article-title":"Exome sequencing of cell-free DNA from metastatic cancer patients identifies clinically actionable mutations distinct from primary disease","volume":"10","author":"Butler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib19","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/1078-0432.CCR-17-0675","article-title":"Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients","volume":"23","author":"Van Roy","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/1878-0261.12077","article-title":"Cell-free DNA copy number variations in plasma from colorectal cancer patients","volume":"11","author":"Li","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib22","first-page":"5171","article-title":"KRAS mutation testing in metastatic colorectal cancer","volume":"18","author":"Tan","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PAP.0b013e3181a9d4ed","article-title":"KRAS mutation testing in colorectal cancer","volume":"16","author":"Plesec","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.molonc.2016.05.009","article-title":"Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery","volume":"10","author":"Denis","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib25","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.3748\/wjg.v23.i39.7087","article-title":"Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR","volume":"23","author":"Olmedillas-Lopez","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib26","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1373\/clinchem.2013.206359","article-title":"Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients","volume":"59","author":"Taly","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ijc.28106","article-title":"KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy","volume":"133","author":"Valtorta","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2012.43.0454","article-title":"KRAS mutation: should we test for it, and does it matter?","volume":"31","author":"Roberts","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.12.005","article-title":"Targeting KRAS mutated non-small cell lung cancer: a history of failures and a future of hope for a diverse entity","volume":"110","author":"Matikas","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/bjc.2012.477","article-title":"KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer","volume":"107","author":"Birkeland","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib31","doi-asserted-by":"crossref","first-page":"21927","DOI":"10.1038\/srep21927","article-title":"Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection","volume":"6","author":"Ostrow","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib32","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1373\/clinchem.2016.255315","article-title":"Multiplex droplet digital PCR quantification of recurrent somatic mutations in diffuse large B-cell and follicular lymphoma","volume":"62","author":"Alcaide","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib33","doi-asserted-by":"crossref","first-page":"a000570","DOI":"10.1101\/mcs.a000570","article-title":"Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers","volume":"1","author":"Laskin","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib34","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1038\/s41598-017-10269-2","article-title":"Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits","volume":"7","author":"Alcaide","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.molonc.2016.10.001","article-title":"Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases","volume":"10","author":"Beije","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib36","doi-asserted-by":"crossref","first-page":"e0161274","DOI":"10.1371\/journal.pone.0161274","article-title":"A robust protocol for using multiplexed droplet digital PCR to quantify somatic copy number alterations in clinical tissue specimens","volume":"11","author":"Hughesman","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib37","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1007\/s00216-015-8773-4","article-title":"ddpcRquant: threshold determination for single channel droplet digital PCR experiments","volume":"407","author":"Trypsteen","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib38","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib39","doi-asserted-by":"crossref","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib40","first-page":"8.17.1","article-title":"Copy-number variants detection by low-pass whole-genome sequencing","volume":"94","author":"Dong","year":"2017","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13008-015-0009-7","article-title":"Aneuploidy and chromosomal instability in cancer: a jackpot to chaos","volume":"10","author":"Giam","year":"2015","journal-title":"Cell Div"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40291-017-0278-8","article-title":"Current and emerging applications of droplet digital PCR in oncology","volume":"21","author":"Olmedillas-Lopez","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib43","doi-asserted-by":"crossref","first-page":"e0174308","DOI":"10.1371\/journal.pone.0174308","article-title":"Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA","volume":"12","author":"Berger","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1200\/JCO.2017.35.4_suppl.334","article-title":"The clinical significance of KRAS monitoring in tumor tissues and blood of patients with pancreatic tumor","volume":"35","author":"Watanabe","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib45","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1038\/s41598-017-08297-z","article-title":"Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer","volume":"7","author":"Del Re","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib46","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-14-0983","article-title":"Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy","volume":"21","author":"Laurent-Puig","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib47","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.18632\/oncotarget.14012","article-title":"Mechanisms of resistance to anti-EGFR therapy in colorectal cancer","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14737159.2016.1123623","article-title":"The clinical potential of enhanced-ice-COLD-PCR","volume":"16","author":"Tost","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib49","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2016.258830","article-title":"Multiplexing of E-ice-COLD-PCR assays for mutation detection and identification","volume":"62","author":"Mauger","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.bjc.6605177","article-title":"KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer","volume":"101","author":"Loupakis","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2018.09.007_bib51","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies","volume":"14","author":"Volik","year":"2016","journal-title":"Mol Cancer Res"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157818301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157818301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:12:20Z","timestamp":1761502340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157818301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1525157818301144"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2018.09.007","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}